Sort
11,323 grants matching “glioblastoma”
Novel role of the polycomb repressive complex PRC2/EZH2 in glioblastoma
$210,351Vishwanath R Iyer · University Of Texas At Austin · R21 · FY2017 · CA
Analysis of Migration Associated Treatment Resistance in Glioblastoma to Identify Novel Therapeutics
$210,318James Battiste · University Of Oklahoma Hlth Sciences Ctr · P20 · FY2021 · GM
DEUTERIUM METABOLIC IMAGING TO NONINVASIVELY MEASURE METABOLIC REPROGRAMMING IN GLIOBLASTOMA
$210,292Washington University, The · · FY2025 · Defense Health Agency
Novel DNA damage response inhibitor and alkylator combinations for GBM
$210,243Ranjit Bindra · Mayo Clinic Rochester · U19 · FY2021 · CA
Genomics & Bioinformatics
$210,225Cameron Brennan · Dana-Farber Cancer Inst · P01 · FY2010 · CA
CORE--IMMUNOLOGICAL MONITORING AND CELLULAR PRODUCT LAB
$210,131University Of Pittsburgh At Pittsburgh · P01 · FY2002 · NS
MODIFICATION OF EFFERENT IMMUNOLOGICAL RESPONSES
$210,131University Of Pittsburgh At Pittsburgh · P01 · FY2002 · NS
Clinical efficacy of the antitumor agent ONC201 in GBM
$210,000Wolfgang Oster · Oncoceutics, Inc. · R44 · FY2015 · CA
Allogeneic glioma vaccine using TGF-beta knockouts
$209,895Novarx Corporation · R44 · FY2004 · CA
A hybrid microvesicle/virus vector for targeted gene transfer to the brain
$209,888Casey A Maguire · Massachusetts General Hospital · R21 · FY2013 · NS
Biodegradable Targeted Nanoparticle for Delivery of Radiosensitizer to Rat Glioma
$209,884G R Reddy · Next Generation Therapeutics, Inc. · R43 · FY2007 · CA
Biostatistics and Bioinformatics Core
$209,803James E Herndon · Duke University · P50 · FY2022 · CA
Tracking the in vivo proliferative history of human glioma-derived stem cells
$209,756Roland Horst Friedel · Icahn School Of Medicine At Mount Sinai · R21 · FY2014 · NS
Identifying the biosynthesis of a potent cytotoxic agent Lasonolide A
$209,674Guojun Wang · Florida Atlantic University · R21 · FY2016 · CA
The role of small RNA modifications in glioma
$209,674Zhangli Su · University Of Alabama At Birmingham · R00 · FY2024 · CA
Core 2: Neuro-Imaging Core (NIC)
$209,647Benjamin M. Ellingson · University Of California Los Angeles · P50 · FY2024 · CA
A 3D ex vivo orthotopic xenograft screening platform to identify radiosensitization targets and druggability in glioma
$209,561Scott R Floyd · Duke University · R21 · FY2019 · CA
Project 4-Oncomodulatory role of HCMV in glial tumors
$209,521Donna M Neumann · Lsu Health Sciences Center · P20 · FY2019 · GM
Vector delivery to modify the brain tumor and its microenvironment
$209,498Joseph C. Glorioso · University Of Pittsburgh At Pittsburgh · P01 · FY2009 · NS
Selective Differentiation of Glioblastoma Stem Cells
$209,456Samuel D Rabkin · Massachusetts General Hospital · R21 · FY2012 · CA
Drug delivery system for enhancing radiation therapy in pediatric glioma
$209,375W Mark Saltzman · Yale University · R21 · FY2018 · HD
Elucidate genetic regulation of GBM differentiation
$209,375Jiangbing Zhou · Yale University · R21 · FY2024 · NS
Host genes controlling rodent protoparvovirus tissue and species tropism
$209,375Peter Tattersall · Yale University · R21 · FY2022 · AI
Deep Learning for Individualized Treatment Effect Inference with Multimodal Depiction
$209,375Xiaofeng Liu · Yale University · R21 · FY2025 · EB
MOLECULAR MARKERS AS PREDICTORS OF OUTCOME IN GLIOMAS
$209,375University Of Pittsburgh At Pittsburgh · R01 · FY2000 · NS